ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,615 | -22.3% | 427,979 | -11.9% | 0.02% | -10.5% |
| Q2 2023 | $14,940 | -17.5% | 486,007 | -3.4% | 0.02% | -20.8% |
| Q1 2023 | $18,119 | -7.9% | 502,887 | +1.0% | 0.02% | -11.1% |
| Q4 2022 | $19,683 | -99.9% | 498,042 | +0.8% | 0.03% | -6.9% |
| Q3 2022 | $19,858,000 | -8.8% | 494,235 | -4.6% | 0.03% | +3.6% |
| Q2 2022 | $21,770,000 | +41.8% | 517,851 | +31.4% | 0.03% | +75.0% |
| Q1 2022 | $15,350,000 | -0.5% | 394,001 | +1.8% | 0.02% | +6.7% |
| Q4 2021 | $15,426,000 | +8.7% | 387,110 | -1.4% | 0.02% | 0.0% |
| Q3 2021 | $14,191,000 | -7.2% | 392,681 | +5.3% | 0.02% | -6.2% |
| Q2 2021 | $15,284,000 | -5.7% | 372,877 | +0.4% | 0.02% | -11.1% |
| Q1 2021 | $16,205,000 | +137.2% | 371,500 | +172.2% | 0.02% | +125.0% |
| Q4 2020 | $6,832,000 | – | 136,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |